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ABSTRACT The cystic fibrosis transmembrane conductance regulator (CFTR) forms a chloride channel that is regulated by
phosphorylation and ATP binding. Work by others suggested that some residues in the sixth transmembrane segment (M6)
might be exposed in the channel and play a role in ion conduction and selectivity. To identify the residues in M6 that are
exposed in the channel and the secondary structure of M6, we used the substituted cysteine accessibility method. We
mutated to cysteine, one at a time, 24 consecutive residues in and flanking the M6 segment and expressed these mutants
in Xenopus oocytes. We determined the accessibility of the engineered cysteines to charged, lipophobic, sulfhydryl-specific
methanethiosulfonate (MTS) reagents applied extracellularly. The cysteines substituted for 1le331, Leu333, Arg334, Lys335,
Phe337, Ser341, 11e344, Arg347, Thr351, Arg352, and Gln353 reacted with the MTS reagents, and we infer that they are
exposed on the water-accessible surface of the protein. From the pattern of the exposed residues we infer that the secondary
structure of the M6 segment includes both a-helical and extended regions. The diameter of the channel from the extracellular
end to the level of Gln353 must be at least 6 A to allow the MTS reagents to reach these residues.
INTRODUCTION
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a member of the ATP-binding cassette (ABC)
membrane transporter gene superfamily (Riordan et al.,
1989). Unlike most members of this superfamily, CFTR
forms an ion channel. This channel has a small conductance
and is anion-selective, with a linear current-voltage relation-
ship (Anderson et al., 1991b; Bear et al., 1991). Channel
gating is regulated by two reactions. The first is phosphor-
ylation by cAMP-dependent protein kinase (Cheng et al.,
1991; Tabcharani et al., 1991; Berger et al., 1993; Chang et
al., 1993; Hwang et al., 1993; Seibert et al., 1995). The
second is ATP binding and hydrolysis at the nucleotide-
binding folds, which induces channel opening and closing
(Anderson et al., 199 la; Smit et al., 1993; Baukrowitz et al.,
1994; Hwang et al., 1994; Carson et al., 1995; Schultz et al.,
1995; Gunderson and Kopito, 1995).
Examination of the amino acid sequence of CFTR sug-
gests that it is a tandem repeat of six membrane-spanning
segments and a nucleotide-binding fold; the two repeats are
connected by a cytoplasmic regulatory domain (R-domain)
(Fig. 1 A) (Riordan et al., 1989). There is considerable
evidence to support the transmembrane topology predicted
from hydropathy analysis. The glycosylation consensus
sites in the putative extracellular loop between M7 and M8
are glycosylated in vivo (Gregory et al., 1990; Chang et al.,
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1994). The insertion of glycosylation sites into each of the
putative extracellular loops in a mutant lacking the wild-
type glycosylation sites yields functional channels that are
glycosylated (Chang et al., 1994). Residues in the R-domain
are phosphorylated in vivo (Cheng et al., 1991; Chang et al.,
1993; Seibert et al., 1995). The binding and hydrolysis of
cytoplasmic ATP, presumably at the nucleotide-binding
folds, are necessary for activation of the channel (Anderson
et al., 1991a; Travis et al., 1993; Baukrowitz et al., 1994;
Winter et al., 1994; Gunderson and Kopito, 1995).
The structure and functions of the cytoplasmic domains
have been extensively studied, but less is known about the
structure of the 12 putative membrane-spanning segments
and their role in forming the chloride channel. There is
evidence that the sixth transmembrane segment (M6) forms
part of the channel lining. A mutation, K335E, in M6 altered
the permeability and conductance ratios for halides (Ander-
son et al., 1991b). In the mutant R347H, multiple ion
occupancy was dependent on the pH of the intracellular
solution, and presumably titration of the histidine altered a
nearby anion-binding site (Tabcharani et al., 1993). The
ability to titrate the histidine in the R347H mutant also
suggests that Arg347 is on the water-exposed surface of the
channel lining. Mutation of the residues Ser341 and Lys335
altered the binding of a voltage-dependent, open channel
blocker, diphenylamine-2-carboxylate (McDonough et al.,
1994). Taken together, these results suggest that the M6
membrane-spanning segment may form a portion of the
channel lining.
To investigate further the structure of the M6 segment
and its role in ion conduction and selectivity, we used the
substituted-cysteine accessibility method to identify the res-
idues in the M6 segment that form the channel lining
(Akabas et al., 1992). In this method we mutate consecutive
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FIGURE 1 Predicted transmembrane topology of CFTR and the amino
acid sequence in and flanking the M6 membrane-spanning segment. (A)
The predicted transmembrane topology of CFTR. NBD, nucleotide binding
domain. (B) The amino acid sequence (single letter code) in and flanking
the M6 membrane-spanning segment. Each of these residues was mutated
to cysteine, one at a time. The membrane-spanning segment as defined by
Riordan et al. (1989) is underlined. EXT, extracellular end; INT, intracel-
lular end.
residues in putative channel-lining segments to cysteine,
one at a time. We express each cysteine substitution mutant
in Xenopus oocytes. We test whether the engineered cys-
teine is on the water-accessible surface of the protein by
determining the susceptibility of the cysteine to covalent
modification by water-soluble, charged, sulfhydryl-specific
reagents. We assume that among the residues in membrane-
spanning segments only those residues exposed in the chan-
nel will be accessible to reaction with these hydrophilic
reagents. We assume further that if these reagents react with
a channel-lining cysteine, conduction through the channel
will be irreversibly altered. We infer that if an engineered
cysteine reacts with these reagents, then the correspond-
ing wild-type residue is exposed to the inside of the
pore. The reagents that we have used are derivatives
of methanethiosulfonate (MTS) (Akabas et al., 1992;
Stauffer and Karlin, 1994). These MTS derivatives include
the negatively charged MTS-ethylsulfonate (MTSES-,
CH3SO2SCH2CH2SO3f) and the positively charged MTS-
ethylammonium (MTSEA+, CH3SO2SCH2CH2NH3+) and
MTS-ethyltrimethylammonium(MTSET+,CH3SO2SCH2C-
H2N(CH3)3+). These reagents covalently link the charged
portion -SCH2CH2X to free sulfhydryls to form mixed
disulfides. We have previously used this approach to iden-
tify three channel-lining residues in the region from Gly9l
to Pro99 in the extracellular half of the MI membrane-
spanning segment; our results suggested that the secondary
structure of this region is a-helical (Akabas et al., 1994b).
We have previously applied the substituted-cysteine acces-
sibility method to identify the channel-lining residues of
several membrane proteins, including the MI segment of
CFTR (Akabas et al., 1994b), the nicotinic acetylcholine
receptor (Akabas et al., 1992, 1994a; Akabas and Karlin,
1995), and the GABA receptors (Xu and Akabas, 1993; Xu
et al., 1995; Xu and Akabas, 1996). Others have applied this
approach to the dopamine D2 receptor (Javitch et al., 1995)
and voltage-gated potassium channels (Kurz et al., 1995; Lu
and Miller, 1995; Pascual et al., 1995). Site-directed chem-
ical modifications after cysteine mutagenesis has also been
used to study other proteins (Todd et al., 1989; Altenbach et
al., 1990; Jung et al., 1993; Mindell et al., 1994; Slatin et al.,
1994; Steinhoff et al., 1994).
We now report the application of this approach to 24
residues in and flanking the M6 segment of CFTR.
MATERIALS AND METHODS
Oligonucleotide-mediated mutagenesis
The cDNA encoding human CFTR in the pBluescript KS(-) vector
(CFTR-pBS) was obtained from Dr. A. E. Smith (Genzyme; Gregory et al.,
1990). The cysteine-substitution mutants were generated using the altered-
sites mutagenesis procedure (Promega). CFTR-pBS was digested with
XbaI and SphI restriction enzymes, and the resulting 1058-bp fragment was
ligated into the pAlter-1 vector (Promega) cut with the same enzymes.
Oligonucleotides were synthesized to generate the appropriate cysteine
substitutions and to simultaneously introduce silent restriction sites. Mu-
tations were identified by restriction digestion and confirmed by DNA
sequencing.
Preparation of mRNA and oocytes
For in vitro mRNA transcription CFIR-pBS was linearized with SmaI.
Messenger RNA was synthesized, and oocytes from Xenopus laevis were
prepared and maintained as described previously (Akabas et a., 1994b).
One day after the oocytes were harvested, they were injected with 50 nl of
mRNA (200 pg/nl). Experiments were performed I to 6 days after mRNA
injection.
Sulfhydryl reagents
The MTS reagents were synthesized as described previously (Stauffer and
Karlin, 1994).
Electrophysiology
CFTR-induced currents were recorded from individual oocytes under two-
electrode voltage-clamp as described previously (Akabas et al., 1994b).
Electrodes were filled with a 3 M KCI solution and had a resistance of less
than 2 Mfl. The ground electrode was connected to the bath via a 3 M
KCVIagar bridge. During experiments, the oocytes were maintained in
Ca2+-free frog Ringer's solution (CFFR) (115 mM NaCl, 2.5 mM KCI, 1.8
mM MgCl2, 10 mM HEPES, pH 7.5, with NaOH) at room temperature.
The holding potential was maintained at -10 mV. Periodically the holding
potential was ramped from -120 mV to +50 mV over 1.7 s and the current
was recorded. From the resulting current-voltage relationship we deter-
mined the magnitude of the CFTR-induced current at -100 mV and the
corresponding reversal potential. Background currents before the activation
of CFTR were less than 10% of the plateau current and were not subtracted
from the records. In all cases the leak current at -100 mV was less than
500 nA.
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Experimental protocol
We tested the susceptibility of wild-type and mutant CFTR to the MTS
reagents using the following protocol. The CFTR chloride current was acti-
vated by applying a solution to the extracellular bath to increase the intracel-
lular cAMP concentration of the oocyte and thereby activate protein kinase A.
This solution contained 200 ,uM 8-(4-chlorophenylthio)adenosine cyclic
monophosphate (cpt-cAMP), 1 mM 3-isobutyl-1-methylxanthine (IBMX),
and 20 ,uM forskolin in CFFR and is referred to subsequently as cAMP-
activating solution. After the CFTR-induced current reached a plateau, a MTS
reagent was added to the extracellular bath in the cAMP-activating solution for
8 min. The sulfhydryl reagents were applied to the oocytes at the following
equireactive concentrations: 10 mM MTSES-, 2.5 mM MTSEA+, and 1 mM
MTSET+ (Stauffer and Karlin, 1994). To determine whether the effects of the
MTS reagents were irreversible, the MTS reagents were removed by washing
with cAMP-activating solution. Because the magnitude of the plateau current
varied between oocytes, the currents recorded from each oocyte were normal-
ized by the current that was measured immediately before the MTS reagents
were applied to permit the comparison of effects between oocytes. All mutants
were tested in at least two batches of oocytes.
Statistics
Data are presented as means + SEM. Significance was determined by
one-way analysis of variance with the least significant difference post hoc
test (p < 0.05) provided in the SPSS-PC statistical analysis program.
the protein, we mutated the residues 329 to 353 (except for
343), one at a time, to cysteine (Fig. 1). Residue 343 is a
cysteine in wild-type CFTR. We expressed the cysteine-sub-
stituted mutants in Xenopus oocytes. Application of the cAMP-
activating solution stimulated a chloride current in oocytes
expressing each mutant. The peak current at -100 mV was
-7117 ± 511 nA for the wild type, and ranged from -1709
± 124 nA for the R347C mutant to -7709 + 700 nA for the
T339C mutant (Fig. 2 A). The time for the currents to reach a
steady-state level after application of the cAMP-activating
solution was 20 + 1 min for wild type, and ranged from 14 +
2 min for 1344C to 51 + 4 min for T351C (Fig. 2 B).
To test the susceptibility of wild-type CFTR and the
cysteine-substitution mutants to the MTS reagents, after the
activated CFTR-induced current reached a plateau we ap-
plied the MTS reagents to the extracellular bath for 8 min in
the continued presence of the cAMP-activating solution, as
illustrated in Fig. 3. The MTS reagents were then washed
out to determine whether their effects were irreversible. All
of the effects of the MTS reagents that we observed were
irreversible.
Effects of MTS reagents on wild-type cysteines
RESULTS in CFTR
To identify the residues in and flanking the M6 membrane-
spanning segment that are on the water-exposed surface of
As reported previously (Akabas et al., 1994b), extracellular
applications of the MTS reagents to Xenopus oocytes ex-
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FIGURE 2 Peak CFTR-induced currents and time to reach the plateau
current after stimulation with cAMP-activating reagents for 24 cysteine-
substitution mutants and wild-type CFTR. (A) Average peak CFTR-in-
duced current at -100 mV recorded 2 to 4 days after injection of oocytes
with mRNA for each of the cysteine-substitution mutants or wild type
(wild-type data are shown at the Cys343 residue and are indicated by WT).
In all cases the reversal potential of the current was about -10 mV. (B)
Average time after addition of the cAMP-activating reagents for the
chloride current to reach its plateau level in oocytes expressing wild-type
or cysteine-substitution mutant CFTR. CFTR current was activated in
oocytes maintained under two-electrode voltage clamp by the addition of
200 ,uM cpt-cAMP, 20 ,uM forskolin, and 1 mM IBMX to the bath. For
each mutant in (A and B) the mean + SEM is shown for six oocytes.
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FIGURE 3 Effect of the MTS reagents on the CFTR-induced current in
oocytes expressing the R347C mutant. The normalized current at a poten-
tial of -100 mV from individual oocytes under two-electrode voltage
clamp is plotted as a function of time. At the arrows marked cAMP, 200
,uM cpt-cAMP, 20 ,LM forskolin, and 1 mM IBMX were added to the bath
to activate CFTR. After the current reached a plateau, at the arrow, the
MTS reagent was added to the bath in the continued presence of cpt-cAMP,
forskolin, and IBMX; in A only the cAMP reagents were added as a
control; (B) 2.5 mM MTSEA+; (C) 10 mM MTSES-; (D) 1 mM
MTSET+. The currents were normalized to the value of the current
immediately preceding the application of the MTS reagent, as follows: (A)
4565 nA; (B) 1875 nA; (C) 1777 nA; (D) 2837 nA.
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pressing wild-type CFTR had no significant effects on the
CFTR-induced currents. The wild-type CFTR-induced cur-
rents increased by less than 15% during an 8-min applica-
tion of 10 mM MTSES-, 2.5 mM MTSEA+, or 1 mM
MTSET+. Because a similar increase [11 ± 6% (N = 3)
(data not shown)] was observed when buffer alone, without
the MTS reagents, was applied to the oocytes, the increase
is presumably due to continued activation of additional
CFTR channels. Hence, we inferred that either the 17 wild-
type cysteines in CFTR were not accessible to the MTS
reagents, or MTS modifications of these cysteines had no
effect on the CFTR chloride conductance. In particular, we
assume that the lack of effect on wild-type CFTR implies
that the sulfhydryl groups of the four wild-type cysteine
residues in putative membrane-spanning segments M2, M4,
M6 (343), and M7 of CFTR are not facing into the CFTR
pore. In this background, we tested the susceptibility of the
engineered cysteines to the MTS reagents.
Accessibility of substituted cysteines to MTSES-
A 1-min application of 10 mM MTSES- significantly inhib-
ited the CFIR-induced currents of 9 of the 24 cysteine-substi-
tuted mutants (Fig. 4 A), L333C, R334C, K335C, F337C,
S341C, R347C, T351C, R352C, and Q353C. An 8-min appli-
cation of 10 mM MTSES- to these mutants did not markedly
increase the inhibitory effects, except for the mutant Q353C, in
which the extent of inhibition increased (Fig. 4 B); hence the
reactions for the other mutants were complete within 1 min.
Accessibility of substituted cysteines to MTSEA+
and MTSET+
All nine of the mutants that reacted with MTSES- were also
significantly inhibited by a 1-min application of 2.5 mM
MTSEA+ (Fig. 5 A). An 8-min application of 2.5 mM
MTSEA+ to these mutants did not markedly increase the
inhibitory effects (Fig. 5 B); thus the reactions were complete
within 1 min. In addition, both a 1-min and an 8-min applica-
tion of 2.5 mM MTSEA+ significantly inhibited the mutant
1331C (Fig. 5). Another mutant, I344C, reacted with MTSEA+
more slowly, requiring an 8-min application of 2.5 mM
MTSEA+ to significantly alter the current (Fig. 5 B). Unlike its
effect on the other mutants, the reaction of MTSEA+ with
1344C resulted in potentiation of the subsequent current.
We also examined the ability of a larger, permanently
positively charged reagent, MTSET+, to react with three of
the mutants, R334C, R347C, and R352C, that were suscep-
tible to MTSEA+. One-minute and 8-min applications of 1
mM MTSET+ inhibited the CFTIR-mediated current of the
mutants R334C by 53 ± 6% and 52 ± 7% (n = 3); R347C
by 44 ± 2% and 36 + 3% (n = 3) (Fig. 3 D); and R352C
by 46 ± 11% and 54.6 ± 10.5% (n = 3). Thus, these
reactions were complete within 1 min.
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FIGURE 4 The relative effect of 1- and 8-min applications of MTSES-
on wild-type and mutant CFTR-induced currents. The percentage change in
the current (A) 1 min and (B) 8 min after application of 10 mM MTSES-
is shown for wild type (WT) and the 24 cysteine-substitution mutants. The
results for wild type are shown for the C343 position. Negative change
indicates inhibition of the subsequent currents, positive change indicates
potentiation of the subsequent currents. The mean and SEM are shown; the
number of oocytes is shown in parentheses next to the mutant name
between the two panels. Black bars indicate mutants for which the change
was significantly different (p < 0.05) from wild type by one-way ANOVA.
FIGURE 5 The relative effect of 1- and 8-min applications of MTSEA+
on wild-type and mutant CFTR-induced currents. The percentage change in
the current (A) 1 min and (B) 8 min after application of 2.5 mM MTSEA+
is shown for wild type (WT) and the 24 cysteine-substitution mutants. The
results for wild type are shown for the C343 position. Negative change
indicates inhibition of the subsequent currents; positive change indicates
potentiation of the subsequent currents. The mean and SEM are shown; the
number of oocytes is shown in parentheses next to the mutant name
between the two panels. Black bars indicate mutants for which the change
was significantly different (p < 0.05) from wild type by one-way ANOVA.
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DISCUSSION Extent of the M5 to M6 loop
Water-exposed residues in and flanking the
M6 segment
The CFTR-induced currents of 11 of 24 cysteine-substitu-
tion mutants in and flanking the M6 membrane-spanning
segment were irreversibly altered by extracellular applica-
tion of the MTS reagents (Figs. 4 and 5), which, therefore,
reacted with these engineered cysteines. We assume that the
MTS reagents will only react with engineered cysteine
residues that are on the water-accessible surface of the
protein, because these reagents are highly polar and because
the rate of reaction of the MTS reagents with an ionized
thiolate anion is 5 X 109 times faster than the rate of
reaction with the unionized thiol (Roberts et al., 1986); only
sulfhydryls exposed to water will ionize to a significant
extent. We infer that the structure of each mutant is similar
to the structure of wild type because we observed CFTR-
induced currents comparable to wild type in oocytes ex-
pressing each of the 24 cysteine-substitution mutants.
Therefore, for those mutants that reacted with the MTS
reagents, we infer that the corresponding wild-type residues
Ile331, Leu333, Arg334, Lys335, Phe337, Ser341, Ile344,
Arg347, Thr351, Arg352, and Gln353 are on the water-
accessible surface of the protein. We assume that the only
water-accessible surface for residues in membrane-spanning
segments is the surface exposed in the ion channel lumen.
However, residues at the extracellular end of a membrane-
spanning segment or in an extracellular loop may be on the
water-accessible surface of the protein, and therefore may
be accessible to the MTS reagents, but are not part of the
channel lining. As is discussed below, this may be the
situation for residues Ile331 and Lys335.
Our inference that a residue is exposed if it reacts with the
MTS reagents is independent of whether the reaction results in
potentiation or inhibition of the subsequent currents. Elucida-
tion of the mechanism of channel block by the MTS reagents
will require the determination of the effects of modification on
single-channel conductance and open probability. Neverthe-
less, our observation that reaction of both negatively and pos-
itively charged MTS reagents with susceptible residues caused
inhibition implies that the effects of modification may not be
due solely to local electrostatic effects. The slow rate of reac-
tion of MTSEA' with the I344C mutant and the inability of
the larger, anionic MTSES- to react with 1344C suggests that
access of the reagents to this residue may be sterically limited,
possibly by neighboring residues on other membrane-spanning
segments.
It is important to recognize that lack of effect of the MTS
reagents with a particular engineered cysteine does not neces-
sarily imply that the residue is buried. Local steric factors
might prevent reaction, or the chemical modification may alter
single-channel conductance and open probability in a recipro-
cal manner, resulting in little or no change in the macroscopic
current.
The extracellular location of the N-terminal end of the M6
segment has been elegantly demonstrated by glycosylation
site insertion (Chang et al., 1994); however, the precise
residue(s) that begins the membrane-spanning segment has
not been defined. In the original hydrophobicity analysis the
extracellular loop between M5 and M6 was predicted to
consist of a single residue, Lys329 (Riordan et al., 1989). At
least three residues, however, are required for a 1800 turn
(Creighton, 1984); thus the loop may include additional
residues. Because Ile331 does not lie on the side of the helix
that is exposed at more cytoplasmic positions in the M6
segment (Fig. 6; see below) and because CFTR can be
glycosylated when six residues containing a glycosylation
consensus sequence are inserted between Lys329 and
Gly330, the loop is likely to extend at least as far as Ile33 1.
Secondary structure of the M6 segment
Based on the observation that the channel-lining residues in the
extracellular half of the M1 segment lay on one side of the
helix when plotted on an a-helical wheel, we inferred that the
secondary structure was a-helical (Akabas et al., 1994b). In
contrast, the overall pattern of the channel-lining residues in
the M6 segment is not consistent with an a-helical secondary
structure (Fig. 6). Although most of the MTS-accessible resi-
dues lie on what would be one side of an a-helix, there are
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FIGURE 6 a-Helical representations of the residues in and flanking the
M6 membrane-spanning segment of CFTR. Black squares indicate residues
that are susceptible to the MTS reagents; open circles indicate residues that
were not susceptible to the MTS reagents. (A) Helical net representation.
The extracellular end is at the top; the intracellular end is at the bottom. The
x axis represents the position on the circumference of the helix. Residues
that are aligned vertically are on the same face of the helix. The residues
K329 to 1332 are not drawn as a helix, to indicate that they are likely to be
part of the loop connecting M5 and M6. (B) Helical wheel representation
of the residues from L333 to Q353. Note that K335 and Q353 lie on the
opposite side of the helix from the exposed face.
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several notable exceptions: Met348 is predicted to be on the
exposed side of the helix but was unaffected by the MTS
reagents, Ile340 is at the edge of the exposed side of the helix
but was unaffected by the MTS reagents, and the exposed
residues Lys335 and Gln353 are on the opposite side of the
helix from the channel-exposed face.
Based on the accessibility of the residues from Phe337 to
Ile344, we would predict that Met348 should be accessible and
Arg347 should be inaccessible if the secondary structure of the
region from Phe337 to Met348 were a-helical (Fig. 6). Be-
cause the opposite pattern of exposure was observed, i.e.,
Arg347 is accessible and Met348 is not, a possible explanation
is that the secondary structure of the segment from Val345 to
Met348 might be a 310 helix rather than an a helix. In a 310
helix the rotation around the helix axis would be 1200 per
residue, and Arg347 would be on the exposed face, not
Met348. The last turn of an a-helical segment often assumes a
310 helix conformation (Creighton, 1984). Thus, the secondary
structure of the M6 segment might be a-helical above Ile344
and terminate in a 310 helix from Val345 to Met348.
The two exposed residues, Lys335 and Gln353, that are
predicted to be on the opposite side of an a helix from the
channel-exposed face (Fig. 6 B), are each in regions where
three consecutive residues are accessible. At the extracellu-
lar end, in the region of Lys335, this could be consistent
with an a-helical secondary structure, although it could also
be consistent with an extended secondary structure. If the
extracellular end of the M6 segment (333 to 335) is a-he-
lical and extends above the plane of the membrane, then
Lys335 could be exposed to the extracellular bath on the
back side of the helix but not in the channel. In this case the
effects of modification on the K335C mutant by the MTS
reagents would have to be indirect. Alternatively, there
could be an extended secondary structure in this region (333
to 335), exposing all three residues in the channel lining.
The accessibility of three residues at the cytoplasmic end
of M6, in the region of Gln353, is inconsistent with an
a-helical secondary structure. There must be an extended
structure at least in the region of Gln353. This extended
structure might possibly be part of a membrane-embedded,
cytoplasmic loop extending into the channel lumen, as in the
L3 loop of porins (Weiss et al., 1991; Cowan et al., 1992;
Schirmer et al., 1995) and proposed for the P-region of
voltage-gated channels (Kurz et al., 1995; Lu and Miller,
1995; MacKinnon, 1995; Pascual et al., 1995; Sun et al.,
1996) and the M2 segment of the glutamate receptors (Holl-
mann et al., 1994). In CFTR, as in the other channels, such
a channel-embedded loop might be important in forming the
charge selectivity filter, the size selectivity filter, or the gate.
Alternatively, in the cases of Lys335 and Gln353, we do not
know that all of the residues are exposed in the same state of
the channel. All of our experiments have been performed on
channels in the activated state, in which the channel undergoes
rapid transitions between the open and closed states. If the
conformation or the orientation of the M6 segment is different
in the open and closed states, then our pattern of exposed
Although we favor the explanations given above, there
are several other explanations for the accessibility or lack of
accessibility of any given residue that we cannot exclude
and which would alter the interpretation of secondary struc-
ture: 1) Although it is tempting to assume that residues for
which the MTS reagents had no effect are not exposed in the
channel lumen, we cannot rule out the possibility that Ile340
and/or Met348 might be exposed in the channel but did not
react, because of local steric factors. 2) Because we have
measured the effects of modification using macroscopic
currents, it is possible that, for example, modification might
increase open probability but decrease single-channel con-
ductance or vice versa, thereby resulting in an unaltered
macroscopic current. Finally, a cysteine mutation might
distort the local structure, altering the accessibility of the
cysteine relative to the corresponding wild-type residue.
Diameter of the channel lumen
The ability of MTSET+ to react with the R352C mutant
indicates that it can penetrate from the extracellular end to this
level. MTSET+ is roughly cylindrical in shape and would fit
into a right cylinder 6 A in diameter and 10 A in length.
Therefore, the channel diameter from the extracellular enid to
the position of R352C, near the cytoplasmic end of the M6
segment, must be at least 6 A. It is important to recognize that
this is a minimum diameter for the channel from the extracel-
lular end to the level of Arg352. If the size selectivity filter
were located at a more cytoplasmic position than Arg352, then
the channel might only be permeant to smaller anions. Based
on osmotic permeability and tracer flux measurements, water
and urea were permeable through CFTR, but methylglucose,
about 6 A in diameter, and sucrose were impermeant (Hase-
gawa et al., 1992). Several groups have suggested that ATP is
permeant through the CFTR channel (Reisen et al., 1994;
Schwiebert et al., 1995). If ATP is permeant, the channel
diameter must be at least 10 A.
Position of the charge selectivity filter
We found that all of the channel-lining residues are acces-
sible to the cationic reagent MTSEA+. To rule out the
possibility that MTSEA+ was entering the channel as an
uncharged amine, we tested the ability of the permanently
charged reagent, MTSET+, to react with several channel-
lining residues. MTSET+ reacted with residues as cytoplas-
mic as Arg352, confirming that positively charged ions can
enter the channel. This implies that cations can penetrate
from the extracellular end of this anion-selective channel at
least as far as Gln353. Either the charge selectivity filter is
near the cytoplasmic end of the channel, or, because of the
lack of ideal anion selectivity in the CFTR channel, the
permeability ratio of Cl-/Na+ is about 10 (Anderson et al.,
1991b), cations can enter the channel. Measurement of the
rates of reaction will be necessary to determine the position
residues would be a composite of the two conformations.
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Relationship to previous studies of residues in
the M6 segment
The functional roles of residues in the M6 segment have
been studied by other investigators. The CFTR channel
displays anomalous mole fraction effects, which suggests
that the channel contains multiple ion-binding sites. The
multiple ion occupancy effects were eliminated by mutation
of Arg347 to Asp or His, and the single-channel conduc-
tance was reduced (Tabcharani et al., 1993). These authors
concluded that Arg347 must be near an anion-binding site in
the channel; consistent with their conclusions, we have
shown that Arg347 is exposed in the channel lumen. Curi-
ously, the mutation R347E was reported to have little effect
on the relative halide permeability or conductance se-
quences of the channel (Anderson et al., 1991b). The mu-
tation K335E, a water-accessible residue, altered the rela-
tive halide permeability and conductance sequences
(Anderson et al., 199 lb). It did not, however, affect multiple
ion occupancy effects, although it did reduce the single-
channel conductance to about 4 pS (Tabcharani et al., 1993).
Another mutation in M6, S341A, caused a fourfold reduc-
tion in the affinity for the voltage-dependent channel
blocker diphenylamine-2-carboxylate (McDonough et al.,
1994); we have shown that Ser341 is exposed in the channel
lumen and thus could interact with a channel blocker.
Mutations of several residues in the M6 segment have
been identified in patients with cystic fibrosis, including
Arg334, Thr338, and Arg347 (Dean et al., 1990; Nunes et
al., 1991; Tsui, 1992; Audrezet et al., 1993; Ferec et al.,
1993; Saba et al., 1993). Some of these are channel-lining
residues, but others are not (Fig. 6). The mutations R334W
and R347P have been shown to reduce single-channel con-
ductance and open probability (Sheppard et al., 1993).
CFTR may provide insights into structure-
function relationships in other ABC
transport proteins
CFTR is a member of the ABC superfamily (Ames et al.,
1992) that includes transporters such as the multiple drug
resistance P-glycoprotein (Gottesman and Pastan, 1993), the
transporter for antigen presentation (Heemels and Ploegh,
1995), and the STE6 transporter in yeast. Little is known
about the structure of the membrane-spanning segments and
their functional roles in other ABC transporters. Based on
the homology with CFI7R, our studies may provide insights
into the structure of their membrane-spanning domains.
We thank Gilda Salazar-Jimenez, Celeste DeMarco, and Alex Fariborzian
for technical assistance and Drs. Jonathan Javitch and Arthur Karlin for
advice and comments on the manuscript.
This work was supported in part by National Institutes of Health grant
NS30808 and a grant-in-aid from the New York City Affiliate of the
American Heart Association. MA is an Established Scientist of the New
York Heart Association and a recipient of a Klingenstein Award in Neu-
roscience.
REFERENCES
Akabas, M. H., and A. Karlin. 1995. Identification of acetylcholine recep-
tor channel-lining residues in the Ml segment of the a-subunit. Bio-
chemistry. 34:12496-12500.
Akabas, M. H., C. Kaufmann, P. Archdeacon, and A. Karlin. 1994a.
Identification of acetylcholine receptor channel-lining residues in the
entire M2 segment of the a subunit. Neuron. 13:919-927.
Akabas, M. H., C. Kaufmann, T. A. Cook, and P. Archdeacon. 1994b.
Amino acid residues lining the chloride channel of the cystic fibrosis
transmembrane conductance regulator. J. Biol. Chem. 269:
14865-14868.
Akabas, M. H., D. A. Stauffer, M. Xu, and A. Karlin. 1992. Acetylcholine
receptor channel structure probed in cysteine-substitution mutants. Sci-
ence. 258:307-310.
Altenbach, C., T. Marti, H. G. Khorana, and W. L. Hubbell. 1990. Trans-
membrane protein structure: spin labeling of bacteriorhodopsin mutants.
Science. 248:1088 -1092.
Ames, G. F-L., C. S. Mimura, S. R. Holbrook, and V. Shyamala. 1992.
Traffic ATPases: a superfamily of transport proteins operating from
Escherichia coli to humans. Adv. Enzymol. 65:1-47.
Anderson, M. P., H. A. Berger, D. P. Rich, R. J. Gregory, A. E. Smith, and
M. J. Welsh. 1991a. Nucleotide triphosphates are required to open the
CFTR chloride channel. Cell. 67:775-784.
Anderson, M. P., R. J. Gregory, S. Thompson, D. W. Souza, S. Paul, R. C.
Mulligan, A. E. Smith, and M. J. Welsh. 1991b. Demonstration that
CFTR is a chloride channel by alteration of its anion selectivity. Science.
253:202-205.
Audrezet, M. P., B. Mercier, H. Guillermit, I. Quere, C. Verlingue, G.
Rault, and C. F6rec. 1993. Identification of 12 novel mutations in the
CFMR gene. Hum. Mol. Genet. 2:51-54.
Baukrowitz, T., T.-C. Hwang, A. C. Nairn, and D. C. Gadsby. 1994.
Coupling of CFTR CF- channel gating to an ATP hydrolysis cycle.
Neuron. 12:473-482.
Bear, C. E., F. Duguay, A. L. Naismith, N. Kartner, J. W. Hanrahan, and
J. R. Riordan. 1991. CF- channel activity in Xenopus oocytes expressing
the cystic fibrosis gene. J. Biol. Chem. 266:19142-19145.
Berger, H. A., S. M. Travis, and M. J. Welsh. 1993. Regulation of the
cystic fibrosis transmembrane conductance regulator CF- channel by
specific protein kinases and protein phosphatases. J. BioL Chem. 268:
2037-2047.
Carson, M. R., S. M. Travis, and M. J. Welsh. 1995. The two nucleotide-
binding domains of cystic fibrosis transmembrane conductance regulator
(CFTR) have distinct functions in controlling channel activity. J. Biol.
Chem. 270:1711-1717.
Chang, X. B., Y. X. Hou, T. J. Jensen, and J. R. Riordan. 1994. Mapping
of cystic fibrosis transmembrane conductance regulator membrane to-
pology by glycosylation site insertion. J. Biol. Chem. 269:18572-18575.
Chang, X-B., J. A. Tabcharani, Y.-X. Hou, T. J. Jensen, N. Kartner, N.
Alon, J. W. Hanrahan, and J. R. Riordan. 1993. Protein kinase A (PKA)
still activates CFIR chloride channel after mutagenesis of all 10 PKA
consensus phosphorylation sites. J. Biol. Chem. 268:11304-11311.
Cheng, S. H., D. P. Rich, J. Marshall, R. J. Gregory, M. J. Welsh, and A.
E. Smith. 1991. Phosphorylation of the R domain by cAMP-dependent
protein kinase regulates the CFTR chloride channel. Cell. 66:
1027-1036.
Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A.
Pauptit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structures
explain functional properties of two E. coli porins. Nature. 358:727-733.
Creighton, T. E. 1984. Proteins: Structures and Molecular Properties. W.
H. Freeman, New York.
Dean, M., M. B. White, J. Amos, B. Gerrard, C. Steward, K. T. Khaw, and
M. Leppert. 1990. Multiple mutations in highly conserved residues are
found in mildly affected cystic fibrosis patients. Cell. 61:863-870.
Ferec, C., C. Verlingue, H. Guillermit, I. Qu&e, 0. Ragu6n6s, J. Feigelson,
M. P. Audrezet, P. Moullier, and B. Mercier. 1993. Genotype analysis of
adult cystic fibrosis patients. Hum. Mol. Genet. 2:1557-1560.
Gottesman, M. M., and I. Pastan. 1993. Biochemistry of multidrug resis-
tance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:
385-427.
Cheung and Akabas CFTR M6 Segment Channel-Lining Residues 2695
Gregory, R. J., S. H. Cheng, D. P. Rich, J. Marshall, S. Paul, K. Hehir, L.
Ostergaard, K. W. Klinger, M. J. Welsh, and A. E. Smith. 1990.
Expression and characterization of the cystic fibrosis transmembrane
conductance regulator. Nature. 347:382-386.
Gunderson, K. L., and R. R. Kopito. 1995. Conformational states of CFTR
associated with channel gating: the role of ATP binding and hydrolysis.
Cell. 82:231-239.
Hasegawa, H., W. Skach, 0. Baker, M. C. Calayag, V. Lingappa, and A.
S. Verkman. 1992. A multifunctional aqueous channel formed by CFTR.
Science. 258:1477-1479.
Heemels, M. T., and H. Ploegh. 1995. Generation, translocation and
presentation of MHC class I-restricted peptides. Annu. Rev. Biochem.
64:463-492.
Hollmann, M., C. Maron, and S. Heinemann. 1994. N-glycosylation site
tagging suggests a three transmembrane domain topology for the gluta-
mate receptor GluRi. Neuron. 13:1331-1343.
Hwang, T. C., M. Horie, and D. C. Gadsby. 1993. Functionally distinct
phospho-forms underlie incremental activation of protein kinase-
regulated Cl- conductance in mammalian heart. J. Gen. Physiol. 101:
629-650.
Hwang, T. C., G. Nagel, A. C. Nairn, and D. C. Gadsby. 1994. Regulation
of the gating of cystic fibrosis transmembrane conductance regulator Cl
channels by phosphorylation and ATP hydrolysis. Proc. Natl. Acad. Sci.
USA. 91:4698-4702.
Javitch, J. A., D. Fu, J. Chen, and A. Karlin. 1995. Mapping the binding-
site crevice of the dopamine D2 receptor by the substituted-cysteine
accessibility method. Neuron. 14:825-831.
Jung, K., H. Jung, J. Wu, G. G. Prive, and H. R. Kaback. 1993. Use of
site-directed fluorescence labelling to study proximity relationships in
the lactose permease of Escherichia coli. Biochemistry. 32:
12273-12278.
Kurz, L. L., R. D. Zuhlke, H. J. Zhang, and R. H. Joho. 1995. Side-chain
accessibilities in the pore of a K' channel probed by sulfhydryl-specific
reagents after scanning-cysteine mutagenesis. Biophys. J. 68:900-905.
Lu, Q., and C. Miller. 1995. Silver as a probe of pore-forming residues in
a potassium channel. Science. 268:304-307.
MacKinnon, R. 1995. Pore loops: an emerging theme in ion channel
structure. Neuron. 14:889-892.
McDonough, S., N. Davidson, H. A. Lester, and N. A. McCarty. 1994.
Novel pore-lining residues in CFTR that govern permeation and open-
channel block. Neuron. 13:623-634.
Mindell, J. A., H. Zhan, P. D. Huynh, R. J. Collier, and A. Finkelstein.
1994. Reaction of diphtheria toxin channels with sulfhydryl-specific
reagents: observation of chemical reactions at the single molecule level.
Proc. Natl. Acad. Sci. USA. 91:5272-5276.
Nunes, V., P. Gasparini, G. Novelli, A. Gaona, A. Bonizzato, F. Sangiuolo,
A. Balassopoulou, F. J. Gimenez, M. Dognini, M. Ravnik-Glavac, M.
Cikuli, V. Mokini, R. Komel, B. Dallapiccola, P. F. Pignatti, D. Louko-
poulos, T. Casals, and X. Estivil. 1991. Analysis of 14 cystic fibrosis
mutations in five south European populations. Hum. Genet. 87:737-738.
Pascual, J. M., C. C. Shieh, G. E. Kirsch, and A. M. Brown. 1995. K' pore
structure revealed by reporter cysteines at inner and outer surfaces.
Neuron. 14:1055-1063.
Reisin, I. L., A. G. Prat, E. H. Abraham, J. F. Amara, R. J. Gregory, D. A.
Ausiello, and H. F. Cantiello. 1994. The cystic fibrosis transmembrane
conductance regulator is a dual ATP and chloride channel. J. Biol.
Chem. 269:20584-20591.
Riordan, J. R., J. M. Rommens, B. S. Kerem, N. Alon, R. Rozmahel, Z.
Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J. L. Chou, M. T. Drumm, M.
C. lannuzzi, F. S. Collins, and L. C. Tsui. 1989. Identification of the
cystic fibrosis gene: cloning and characterization of complementary
DNA. Science. 254:1066-1073.
Roberts, D. D., S. D. Lewis, D. P. Ballou, S. T. Olson, and J. A. Shafer.
1986. Reactivity of small thiolate anions and cysteine-25 in papain
towards methyl-methanethiosulfonate. Biochemistry. 25:5595-5601.
Saba, L., G. B. Leoni, A. Meloni, V. Faa, A. Cao, and M. C. Rosatilli.
1993. Two novel mutations in the transmembrane domains of the CFTR
gene in subjects of Sardinian descent. Hum. Mol. Genet. 2:1739-1740.
Schirmer, T., T. A. Keller, Y.-F. Wang, and J. P. Rosenbusch. 1995.
Structural basis for sugar translocation through maltoporin channel at 3.1
A resolution. Nature. 267:512-514.
Schultz, B. D., C. J. Venglarik, R. J. Bridges, and R. A. Frizzell. 1995.
Regulation of CFTR Cl- channel gating by ADP and ATP analogues.
J. Gen. Physiol. 105:329-361.
Schwiebert, E. M., M. E. Egan, T. H. Hwang, S. B. Fulmer, S. A. Allen,
G. R. Cutting, and W. B. Guggino. 1995. CFTR regulates outwardly
rectifying chloride channels through an autocrine mechanism involving
ATP. Cell. 81:1063-1073.
Seibert, F. S., J. A. Tabcharani, X. B. Chang, A. M. Dulhanty, C. Mathews,
J. W. Hanrahan, and J. R. Riordan. 1995. cAMP-dependent protein
kinase-mediated phosphorylation of cystic fibrosis transmembrane con-
ductance regulator residue Ser-753 and its role in channel activation.
J. Bio. Chem. 270:2158-2162.
Sheppard, D. N., D. P. Rich, L. S. Ostedgaard, R. J. Gregory, A. E. Smith,
and M. J. Welsh. 1993. Mutations in CFTR associated with mild-
disease-form CF- channels with altered pore properties. Nature. 362:
160-164.
Slatin, S. L., X. Q. Qiu, K. S. Jakes, and A. Finkelstein. 1994. Identification
of a translocated protein segment in a voltage-dependent channel. Na-
ture. 371:158-161.
Smit, L. S., D. J. Wilkinson, M. K. Mansoura, F. S. Collins, and D. C.
Dawson. 1993. Functional roles of the nucleotide-binding folds in the
activation of the cystic fibrosis transmembrane conductance regulator.
Proc. Natl. Acad. Sci. USA. 90:9963-9967.
Stauffer, D. A., and A. Karlin. 1994. Electrostatic potential of the acetyl-
choline binding sites in the nicotinic receptor probed by reactions of
binding-site cysteines with charged methanethiosulfonates. Biochemis-
try. 33:6840-6849.
Steinhoff, H.-J., R. Mollaaghababa, C. Altenbach, K. Hideg, M. Krebs, H.
Gobind Khorana, and W. L. Hubbell. 1994. Time-resolved detection of
strucutral changes during the photocycle of spin-labeled bacteriorhodop-
sin. Science. 266:105-107.
Sun, Z. P., M. H. Akabas, E. H. Goulding, A. Karlin, and S. A. Siegelbaum.
1996. Exposure of residues in the cyclic-nucleotide-gated channel pore:
P region structure and function in gating. Neuron. 16:141-149.
Tabcharani, J. A., X. B. Chang, J. R. Riordan, and J. W. Hanrahan. 1991.
Phosphorylation-regulated Cl- channel in CHO cells stably expressing
the cystic fibrosis gene. Nature. 352:628-631.
Tabcharani, J. A., J. M. Rommens, Y. X. Hou, X. B. Chang, L. C. Tsui, J.
R. Riordan, and J. W. Hanrahan. 1993. Multi-ion pore behavior in the
CFTR chloride channel. Nature. 366:79-82.
Todd, A. P., J. Cong, F. Levinthal, C. Levinthal, and W. L. Hubbell. 1989.
Site-directed mutagenesis of colicin El provides specific attachment
sites for spin labels whose spectra are sensitive to local conformation.
Proteins. 6:294-305.
Travis, S. M., M. R. Carson, D. R. Ries, and M. J. Welsh. 1993. Interaction
of nucleotides with membrane-associated cystic fibrosis transmembrane
conductance regulator. J. Biol. Chem. 268:15336-15339.
Tsui, L-C. 1992. Mutations and sequence variations detected in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene: a report
from the cystic fibrosis genetic analysis consortium. Hum. Mutat.
1:197-203.
Weiss, M. S. U. Abele, J. Weckesser, W. Welte, E. Schiltz, and G. E.
Schulz. 1991. Molecular architecture and electrostatic properties of a
bacterial porin. Science. 254:1627-1630.
Winter, M. C., D. N. Sheppard, M. R. Carson, and M. J. Welsh. 1994.
Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis
of channel regulation. Biophys. J. 66:1398-1403.
Xu, M., and M. H. Akabas. 1993. Amino acids lining the channel of the
-y-aminobutyric acid type A receptor identified by cysteine substitution.
J. Biol. Chem. 268:21505-21508.
Xu, M., and M. H. Akabas. 1996. Identification of channel-lining residues
in the M2 membrane-spanning segment of the GABAA receptor aI
subunit. J. Gen. Physiol. 107:195-205.
Xu, M., D. F. Covey, and M. H. Akabas. 1995. Interaction of picrotoxin
with GABAA receptor channel-lining residues probed in cysteine mu-
tants. Biophys. J. 69:1858-1867.
